Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
Filter by Infection
Filter by Resource Category
Search results
Current filters: HIV, Treatment, HIV drugs
149 search results
- FDA warns that Prezcobix should not be used by HIV-positive pregnant women
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - CDC recommends use of raltegravir (Isentress) for PEP
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Biktarvy in women with HIV
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Switching from Triumeq to Biktarvy
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Switching to Biktarvy from a protease inhibitor–based regimen
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Biktarvy becomes a treatment option in Canada
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Agencies issue caution about use of dolutegravir by pregnant HIV-positive women
-
2018, CATIE
Research summary - Webpage - Dutch study ties HIV to erection problems in middle-aged men
-
2018, CATIE
Research summary - Webpage - Winnipeg doctors use dolutegravir and darunavir for simplifying treatment
-
2018, CATIE
Research summary - Webpage - Preliminary results of dolutegravir + 3TC for initial therapy of HIV
-
From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage
